This AI-designed drug for IBD was just given to human subjects for the first time
Absci entered its new drug into Phase I trials in half the time and for many millions of dollars less than it would have cost without AI.

May 12, 2025 0
May 12, 2025 0
May 14, 2025 0
May 12, 2025 0
May 12, 2025 0
May 12, 2025 0
May 12, 2025 0
May 14, 2025 0
May 13, 2025 0
May 12, 2025 0
May 12, 2025 0
May 12, 2025 0
May 13, 2025 0
May 12, 2025 0
May 12, 2025 0
May 14, 2025 0
May 13, 2025 0
May 13, 2025 0
May 12, 2025 0
May 12, 2025 0
Or register with email
May 12, 2025 0
May 12, 2025 0
May 13, 2025 0
May 12, 2025 0
May 12, 2025 0
This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.